$0.5817
-0.0203-3.37%
Last update: Oct 30, 7:58 PM
Invivyd Inc (IVVD) Stock Price, Quote, News & History
IVVDNASDAQ
Invivyd reported Phase 3 LIBERTY trial data for VYD2311, showing strong safety and enhanced COVID-19 antibody levels.
You can purchase shares of Invivyd (NASDAQ:IVVD) through any online brokerage.
Other companies in Invivyd’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Invivyd has a consensus price target of $7.57.
The stock price for Invivyd (NASDAQ: IVVD) is $0.6048 last updated October 30, 2026 at 7:58 PM EDT.
There are no upcoming dividends for Invivyd.
Invivyd does not have any upcoming earnings scheduled.
There is no upcoming split for Invivyd.
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA...
